4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000125
Chief Medical Officer acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2022-08-09 | Grant or award | +22,500 | 110,597 | D: show line 1 in the form |
Loading xslF345X03/wf-form4_166026015800698.xml…